Bluejay Diagnostics, Inc. Operating Lease, Expense
Bluejay Diagnostics, Inc. (BJDX) reported Operating Lease, Expense of $168.71 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-08-14
- Bluejay Diagnostics, Inc. operating lease, expense for the quarter ending 2023-06-30 was $4.00.
- Bluejay Diagnostics, Inc. operating lease, expense for the quarter ending 2023-03-31 was $168.71K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 12 month |
|---|---|---|---|
| 2023-06-30 | $4.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $168.71K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $168.71K 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | $168.71K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |